WNSPFWUSQSIWRE-YTTGMZPUSA-N
C37H38ClF3N4O4S — CID 134399887
Data last refreshed: (MolForge compound catalog, from PubChem)
About WNSPFWUSQSIWRE-YTTGMZPUSA-N
WNSPFWUSQSIWRE-YTTGMZPUSA-N (PubChem CID 134399887) has the molecular formula C37H38ClF3N4O4S and a molecular weight of 727.25 g/mol. Its IUPAC name is (2S)-2-[7-(4-chlorophenyl)-5-methyl-2-[3-[1-(oxetan-3-yl)piperidin-4-yl]-1-(2,2,2-trifluoroethyl)indazol-5-yl]-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid.
Molecular Properties
| Compound Name | WNSPFWUSQSIWRE-YTTGMZPUSA-N |
|---|---|
| PubChem CID | 134399887 |
| Molecular Formula | C37H38ClF3N4O4S |
| Molecular Weight | 727.25 g/mol |
| Exact Mass | 726.23 |
| IUPAC Name | (2S)-2-[7-(4-chlorophenyl)-5-methyl-2-[3-[1-(oxetan-3-yl)piperidin-4-yl]-1-(2,2,2-trifluoroethyl)indazol-5-yl]-1,3-benzothiazol-6-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid |
| SMILES | Cc1cc2nc(-c3ccc4c(c3)c(C3CCN(C5COC5)CC3)nn4CC(F)(F)F)sc2c(-c2ccc(Cl)cc2)c1[C@H](OC(C)(C)C)C(=O)O |
| InChI | InChI=1S/C37H38ClF3N4O4S/c1-20-15-27-33(30(21-5-8-24(38)9-6-21)29(20)32(35(46)47)49-36(2,3)4)50-34(42-27)23-7-10-28-26(16-23)31(43-45(28)19-37(39,40)41)22-11-13-44(14-12-22)25-17-48-18-25/h5-10,15-16,22,25,32H,11-14,17-19H2,1-4H3,(H,46,47)/t32-/m0/s1 |
| InChIKey | WNSPFWUSQSIWRE-YTTGMZPUSA-N |
| XLogP | 9.02 |
| TPSA | 89.71 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 727.25 |
| LogP ≤ 5 | 9.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134399887 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.